Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

December 20, 2023

https://www.globenewswire.com/news-release/2023/12/20/2799194/0/en/Recursion-and-Enamine-to-Generate-and-Design-Enriched-Compound-Libraries-for-Global-Drug-Discovery-Industry.html

KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its partnership with Enamine, a world-renowned provider of novel molecules and contract research services, to generate enriched screening libraries with insights from Recursion’s protein-ligand interaction predictions spanning across Enamine’s massive library of 36 billion compounds.

Read more at globenewswire.com

Related news for (RXRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.